Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

(2010) SHARP Collaborative Group   AMERICAN HEART JOURNAL

An update on the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design

(2010) Robert M. Califf et al.   AMERICAN HEART JOURNAL

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)

(2010) Gianluca Bardini et al.   Cardiovascular Diabetology

Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus

(2010) Kenta Okada et al.   ENDOCRINE JOURNAL

Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets

(2010) T. McCormack et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes

(2010) Carlo M Rotella et al.   Lipids in Health and Disease

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

(2009) Kornelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified by National Cholesterol Education Program Risk Category

(2009) Adam B. Polis et al.   Metabolic Syndrome and Related Disorders

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

(2008) Christopher P. Cannon et al.   AMERICAN HEART JOURNAL

Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy

(2008) Thomas A. Pearson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy

(2008) Laurent Laforest et al.   ATHEROSCLEROSIS

The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study

(2008) Henk W. O. Roeters van Lennep et al.   CURRENT MEDICAL RESEARCH AND OPINION

Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

(2008) J. D. Brunzell et al.   DIABETES CARE